GINA strategy 2021: management of asthma
This Guidelines summary outlines recommendations for the management of asthma in adults, adolescents, and children aged 6–11
NICE asthma guideline: chronic asthma management
A practical summary of NICE recommendations on managing chronic asthma in children, young people, and adults, including three management algorithms
NICE asthma guideline: diagnosis and monitoring
A concise summary on the initial assessment, diagnosis, and monitoring of asthma in adults, young people, and children. Includes assessment algorithms
GOLD COPD 2021 strategy
A clear summary of GOLD’s 2021 strategy on COPD diagnosis, management, and prevention, including recommendations on COVID-19 and COPD
BTS/SIGN asthma in pregnancy guideline
This summary focuses on recommendations for the management of asthma in pregnant women, including during labour, and recommendations for breastfeeding mothers
Inhaler choice guideline
This management algorithm was developed by a multidisciplinary expert panel: Usmani et al and supported by Chiesi Ltd through the provision of a grant for its production.
BTS/SIGN management of difficult asthma guideline
This brief summary of BTS/SIGN guidance on the assessment and management of difficult asthma includes information on contributory factors and monitoring.
COVID-19 rapid guideline on COPD
The purpose of this summary is to maximise the safety of patients with chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources. For more detailed information, please refer to the full guideline.
COVID-19 rapid guideline on severe asthma
The purpose of this guideline is to maximise the safety of adults and children with severe asthma during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources.
NICE antibiotics for COPD exacerbations guideline
This concise summary covers what to be aware of when considering antimicrobials for an acute exacerbation of COPD to avoid unnecessary prescribing.
Resource hub
Inhaler standards and competency document
- Previous
- Next
Educational resources
COPD: LAMA/LABA therapy—Real life case studies
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200015 V2.0
Why you might want to review patients with COPD receiving a LAMA
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200013
COPD: Have you done enough to implement guidelines?
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200012
Why use LAMA/LABAs as initial maintenance therapy in specific COPD patients?
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200011
LAMA/LABAs as initial maintenance therapy in COPD
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200010